To do so, we combined the analyses of different CAF markers, including FAP, CD29, SMA and FSP1 (see Supplementary Table S1 for antibody references) for differentiating the four CAF populations (referred to as CAF-S1 to CAF-S4) that we previously identified in several cancer types, including ovarian cancer40,67,68,80. Here, SMN1 is linked to cancer.